PATENT CLAIM ANALYSIS

Application Number: 15762737
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "093210"]

Abstract:
A chimeric antigen receptor including a co-inhibitory receptor signaling domain, as well as a nucleic acid construct and immune cells expressing the same are described. Kits and methods of using the immune cells in the treatment or amelioration of chronic inflammation or immune-mediated autoimmunity are also provided.

Claim (Index 7):
An immune cell comprising nucleic acids encoding the chimeric antigen receptor of  claim 1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.31579
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14835264', '15476699', '15093643', '14018021', '15008376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6531879950704575
- 35 USC 102 Novelty (BERT): 0.4881578437573716
- Combined Prediction Score: 0.636684979939149
- Mean Citation Score: 224.001616
- Max Citation Score: 229.87688
- Similarity Product: 192.59770689188

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test